NIOX Group (LON:NIOX) Posts Earnings Results

NIOX Group (LON:NIOX) announced its quarterly earnings results on Tuesday. The company reported GBX 4.03 earnings per share (EPS) for the quarter, Digital Look Earnings reports. NIOX Group had a return on equity of 8.39% and a net margin of 11.30%.

NIOX Group Price Performance

LON:NIOX traded up GBX 3.60 during trading hours on Tuesday, reaching GBX 58. 3,141,842 shares of the company were exchanged, compared to its average volume of 815,796. The company has a market capitalization of £242.40 million, a P/E ratio of 46.40 and a beta of 0.92. NIOX Group has a 1-year low of GBX 53.40 and a 1-year high of GBX 77.60. The company has a debt-to-equity ratio of 1.86, a current ratio of 3.73 and a quick ratio of 1.94. The business has a 50 day moving average of GBX 64.53 and a 200 day moving average of GBX 68.35.

Analyst Ratings Changes

Separately, Deutsche Bank Aktiengesellschaft decreased their price objective on shares of NIOX Group from GBX 90 to GBX 86 and set a “buy” rating on the stock in a report on Wednesday, January 21st. Two analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of GBX 88.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.